Brigham and Women’s Hospital, associated with Harvard Medical School, is home to an Advanced Center for Parkinson’s Research supported by the American Parkinson Disease Association. The Center is directed by Clemens Scherzer, M.D. with a comprehensive team of experts.
The funding of this Center supports a large research program, which includes: basic, translational, and clinical research, as well as outreach for building a community of patient-partners, and the education and training of the next generations of scientists and clinicians dedicated to solving PD.
The American Parkinson Disease Association (APDA) is the largest grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to assist the more than 1 million Americans with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $170 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease. To join us in the fight against Parkinson’s disease and to learn more about the support APDA provides nationally through our network of Chapters and Information & Referral (I&R) Centers, as well as our national Research Program and Centers for Advanced Research, please visit us at www.apdaparkinson.org.
Parkinson’s disease affects more than 1 million people in the United States annually, with at least 60,000 new cases diagnosed each year. The chronic and progressive neurological condition is the second most common neurodegenerative aging disorder, after Alzheimer’s disease.